I need more information to create a summary. Please provide a description of what this document is about, including relevant facts such as deadlines, dollar amounts, affected industries, or scope for small businesses.
FDA corrects contact information for the Expedited Investigational New Drug Pilot Program docket, which solicits public input on shortening timelines from drug identification to first-in-human clinical trials.
Tell Bizmoon what your business does and we'll cut the Federal Register down to what actually matters.
Every rule is broken into specific to-dos with calendar dates.
We tell you which parts of your business each rule actually touches.
After healthcare come the capital-heavy sectors: trade, transportation, energy, and finance. If you operate in one of them, the volume of change is relentless.
National Securities Clearing Corporation proposes enhancements to supplemental liquidity deposit rules, methodology, and processes for member firms.
The FDA seeks OMB clearance for information collection procedures related to premarket approval of medical devices under the Paperwork Reduction Act.
NYSE American amends its connectivity fee schedule for market data and trading access; the rule change is effective immediately.
NYSE Arca proposes amendments to its connectivity fee schedule, effective immediately upon SEC filing.
NYSE Texas, Inc. amends its connectivity fee schedule to adjust charges for market data and trading access services.
NYSE American modifies its options fee schedule for manual transactions, with changes effective immediately.
FDA withdraws approval of 34 new drug applications across multiple applicants whose manufacturers requested withdrawal due to discontinued marketing.
The SEC proposes to extend its information collection for Rule 6e-2 and Form N-6EI-1, which requires certain investment companies to file reports on insurance company variable annuity operations.
No legal jargon. Read the impact in two sentences.
Email + dashboard pings the moment something changes.
